Koninklijke Philips NV ADR (PHG) - Stock & Dividends

Exchange: USA Stocks • Country: Netherlands • Currency: USD • Type: Common Stock • ISIN: US5004723038

(NYSE:PHG Stock) Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. It operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. The company provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease; proprietary software to enable diagnostics and intervention; and enterprise diagnostic informatics products and services. It also offers acute patient management solutions; emergency care solutions; sleep and respiratory care solutions; and electronic medical record and care management solutions. In addition, the company provides power toothbrushes, brush heads, and interdental cleaning and teeth whitening products; infant feeding, baby monitors, and digital parental solutions; and grooming and beauty products and solutions. It has strategic partnership agreements with TriHealth, Prisma Health, and the University Health System of San Antonio to help the health system standardize patient monitoring, drive interoperability, and lay the foundation for enterprise-wide platform; and Oulu University Hospital to deliver advanced image-guided therapy solutions. The company was formerly known as Koninklijke Philips Electronics N.V. and changed its name to Koninklijke Philips N.V. in May 2013. Koninklijke Philips N.V. was founded in 1891 and is headquartered in Amsterdam, the Netherlands. Web URL: https://www.philips.com

Drawdown (Underwater) Chart

Drawdown / Underwater Chart for Koninklijke Philips NV ADR (PHG) - Stock & Dividends

PHG Stock Overview

Market Cap in USD 18,672m
Sector Healthcare
Industry Medical Devices
GiC SubIndustry Health Care Equipment
TER 0.00%
IPO / Inception 1987-12-30

PHG Stock Ratings

Fundamental -
Dividend 1.71
Growth 5y -2.13
Rel. Performance vs Sector 0.94
Analysts 3.00
Fair Price Total Ret. 17.85
Fair Price DCF -

PHG Dividends

Yield 12m 0.00%
Yield on Cost 5y 0.00%
Dividends CAGR 5y -100.00%
Payout Consistency 76.3%

PHG Growth Ratios

Growth 12m 23.85%
Growth Correlation 12m 42%
Growth Correlation 3m -4%
CAGR 5y -9.75%
CAGR / Mean Drawdown -0.30
Sharpe Ratio 12m 0.58
Alpha vs SP500 12m -2.01
Beta vs SP500 5y weekly 0.96
CAPM 7.90%
Average Daily Range 2m 1.33%
Regime Oscillator 12.15
Volatility GJR Garch 1y 31.38%
Price / SMA 50 -10.21%
Price / SMA 200 -5.11%
Current Volume 1421.8k
Average Volume 20d 1424.4k

External Links for PHG Stock

News
Wall Street JournalBenzingaYahoo Finance
Tweets
X (Twitter)Stocktwits
Fund Manager Positions
DataromaStockcircle
What is the price of PHG stocks?
As of February 22, 2024, the stock is trading at USD 19.87 with a total of 1,421,816 shares traded.
Over the past week, the price has changed by -1.00%, over one month by -15.34%, over three months by -5.92% and over the past year by +23.63%.
Why is PHG stock down?
Check with which Index or Commodity PHG has the highest Correlation, do they have a common driver?
Review the Fundamentals to find weaknesses (Debt, low returns). Check the Performance of the Peer-Group to find out, if the entire sector is under pressure.
Period Return PHG Return S&P 500
1 Month -15.34% 2.85%
3 Months -5.92% 10.14%
12 Months 23.63% 26.48%
What is the forecast for PHG stock price target?
According to ValueRays Forecast Model, PHG Koninklijke Philips NV ADR will be worth about 19.3 in February 2025. The stock is currently trading at 19.87. This means that the stock has a potential downside of -3.02%.
Issuer Forecast Upside
Wallstreet Target Price 21.7 9.1%
Analysts Target Price 17.4 -12.2%
ValueRay Target Price 19.3 -3.0%